Pionyr Phase 1a Study of TREM2-targeting Antibody PY314 for the Treatment of Solid Tumors Featured at ASCO 2022May 26, 2022Sharefile does not exist at PATH: /nas/content/live/sofinnova/build/images/icons/facebook.svgfile does not exist at PATH: /nas/content/live/sofinnova/build/images/icons/linkedin.svgfile does not exist at PATH: /nas/content/live/sofinnova/build/images/icons/twitter.svgSharefile does not exist at PATH: /nas/content/live/sofinnova/build/images/icons/facebook.svgfile does not exist at PATH: /nas/content/live/sofinnova/build/images/icons/linkedin.svgfile does not exist at PATH: /nas/content/live/sofinnova/build/images/icons/twitter.svg
